Btg Share Discussion Threads

[dp1umb] 27/9/2017 09:10

More than likely to do with Trump and Obamacare.

[fhmktg] 27/9/2017 08:56

And maybe the market is beginning to react?Could just be trading down ahead of the close period update next week.

[minerve] 26/9/2017 23:02

Advice does not equal instruction.

[cockneytrader] 26/9/2017 13:43

Btg have got off lightly for the time being. The meeting with at analysts at the Nov meeting may prove tricky.

My own analysis. Why pay external consultants money to give advice only not to follow that advice?

The current BOD need a shake, and heads need to role. $55 million and costs is a lot of money. Maybe, BTG need to pay a dividend to shareholders, that will concentrate minds.

[adejuk] 25/9/2017 16:14

here we go

[dr biotech] 25/9/2017 11:20

I have AV/GSK/LLOY - and BT. Currently I am about 50/50 between income & growth. More than half is in Woodford/Standard Life Smaller Cos and Marlborugh small caps. The latter two have really out performed.

I am thinking about early retirement and want to generate a tax free income of about 30k - think I'll need around 700k for that. Hopefully possible in 7-10 years

[dp1umb] 25/9/2017 10:35

Dr Biotech. IMHO Vectura look cheap at the moment also directors have been buying lately , but no income. Glaxo pay aroun 6% and may be about to start growing again.But if it's just income your after I would slip between lloyds, Aviva and glaxo.

Vectura have the same problems as BTG i.e. Litigation overshadowing the stock but they have lost about 50% of there value,also the directors share purchases add confidence (when was the last time a board member at BTG put there hands in there pockets and purchased a substantial stake??)

[dr biotech] 25/9/2017 07:28

I continue to hold. Im sitting on about 30% cash at the moment unsure where to put it. Really I need to focus more on income rather than growth stocks so it won't go here.

I think it's reasonable value at current levels..my record is moderate so I'd never give any investment advice.

[bargainbob] 24/9/2017 14:35

Would you buy at the Moment Dr Biotec ?

[dr biotech] 24/9/2017 13:55

A bit from TMF. I am not a fan of them - I find their articles anodyne and generic - as if they are written to a template.

Growth champion

Speciality pharmaceutical company BTG (LSE: BTG) is projected to grow earnings per share by 29% for the fiscal year ending 31 March 2018 as pre-tax profit surges 370%.

At the beginning of July, management confirmed that the company is on track to hit this target as it is set to achieve "double-digit product sales growth" for the year ending March 31 2018, driven by growth in its interventional medicines business. As well as growth in the established business, BTG is progressing well with the development of new products, receiving positive outcomes from two clinical trials for its blood clot treatment Ekos, varicose vein treatment Varithena and PneumRx coils products.

Shares in BTG are not cheap, trading at a forward P/E of 22.2 but considering the company's growth rate, and treatment pipeline, I believe this is a premium worth paying. Indeed, at the time of writing, the shares are trading at a PEG ratio of 0.8, implying that they offer growth at a reasonable price.

[bargainbob] 23/9/2017 10:22

From Dave on eye eye eye

Im SORRY but my last post should not have been posted, as it wasn’t finished, I must have hit the wrong button before leaving my computer this morning.
---- ---------------------------------------------------------------------------------
Reading the judgement posted here on the BB it makes my blood boil ,to read BTG were first approached by wellstadt with their suspicions many years ago but instead of talking to wellstadt, our management decided to instigated a breach of contract law suit against wellstadt instead ,now had the management agreed back then to return to the terms of that agreement ,then none of this would have happened ,and we would still be selling a licenced product for profit. How mad is that ?.

I know from my own experience ,the last thing you do is attack a customer ,or a company you are working with, unless your 100% confident they had done something wrong, and that you could prove in a court of law and after talking to the company, to see if you could iron out the difficulties amicably ,but it appears in this case, BTG didn't do that ,and that to me ,that is asking for trouble.

What's even more concerning about this, is that control of the sales & marketing budgets were changed after the agreement was signed, and would be detrimental to the launch of wellstedt product, and would break the terms of our contract with wellstadt, yet nobody at BTG saw this as a problem .

To me all of this could have been avoided, had the BOD listened to Wellstads grievances in 2015. Had they done that ,then we wouldn’t be losing a product that could have made BTG a very good profit over many years, and for what is said to have been a very little amount of outlay according to the trial notes, and that to me is unforgivable, how this will play out with other clients, or with future clients ,I just don’t know, but as we all know 50% of business is about trust ,and if you lose that in the USA , then you are finished as most medical products in the U.S.A are purchased through a medical insurance syndicate .

This whole sorry business shows how bad our marketing has been over the years, it could also explain why other BTG products we have launched in the USA, have also failed to meet expectations, or their growth predictions over the years ,and is something I, and many other posters on this BB have queried on several occasions , well maybe now we have the answer to all those questions ,as It seems to me, BTG either have a poor sales &marketing dept ,or B.T.G, lack the experience in the top echelons of the company, when it comes to sales &marketing .

I know from my own experience in manufacturing and retail that most companies in UK today employ professional sales and marketing people ,as they know how to support a team of sales people and also know how to distribute a sales team across an area in order to maximise sales, they are also aware of the importance of marketing when launching a new product ,it’s their expertise of the market that is key to the success or failure of a product ,so if ,but if our management team can’t do that with in a set budget then heads should roll, I also believe ,that any shares received by the BOD through the BTG share initiative, should now be returned/or the cash repaid to the company, as they obviously failed in their responsibilities to the protect B.T.G shareholders profits, and the good name of the company ,But had the BOD acted upon wellstadt complaint back in 2015 things might be different now .

Obviously we will never know the full story of what happened, or who was to blame for this mess ,but this sorry tale could have been soughed out amicably in 2015, and hopefully it still can be, as the judge has given both parties 21 days to find a settlement before ordering costs and payment .
BE HAPPY
DAVE ..

[bill hunt] 22/9/2017 12:00

The Change in strategy by the board has to be weighed against the profits from the change and the court losses. Without exact figures this is difficult to assess. The growth strategy adopted has a few years to run. The reading of the judgement does show a lack of acumen on the behalf of the board in relation to contract law. A glaring error but if the change in strategy produces Economic results then the board may feel justified despite their moral failings.

[fhmktg] 22/9/2017 12:00

And. Mr Higham!

[adejuk] 22/9/2017 11:43

bob, we are the market - we have noticed. so have the instis
fact is that it is not terribly important in the grand scheme
a bargain at this share price imo

[bargainbob] 22/9/2017 07:47

The market has not noticed this . They need to do a out of court agreement asap.

[fhmktg] 22/9/2017 00:28

If this goes to conclusion as is, then the reputational damage will be serious and could pose problems in future negotiations for M&A activities.The court has given a very short time to resolve the issue and 1% monthly compound interest from 2015!

[bargainbob] 21/9/2017 22:58

Damming court document about BTG. I wonder how many salesman could have been hired for the cash BTG will now in all likelyhood pay. Yesderday RNS is a tad misleading , looks like .BTG really messed up with the blame fully on Louise.

Sadly it explains the slow uptake of Varisolve , a word to Louise it great to have cutting Edge tech. However that is no use if your marketing and launch are choked .
Explains a lot imho.

[dp1umb] 20/9/2017 18:13

I don't want to go on but it makes my blood boil.

Look at the BP accident in the Gulf of Mexico ok it was a bad environment disaster but the fine and compensation cost nearly took BP down.But decades before an American oil company had a much worse environment disaster and I think the fines equated to about half of there annual profits!!!! Then there was the smokers widow who was awarded "don't be sick " $23.6 billion now she maybe is entitled to some damages but what about all the other widows

[dp1umb] 20/9/2017 18:02

How do they get to the figure of $55m it seems very high for a breach of distribution agreement???

If you can remember a few years back BTG took Apple,Samsung maybe even ARM to court about a patent infringement I think to do with flash media? Now BTG won that case or settled out of court at the eleventh hour!!!

The damages awarded/received were so substantial not one of use could even say what they were,ie (next to nothing) the American legal system is the swamp that Trump should be draining but I suppose it's America first like a previous poster stated.

[waterloo01] 20/9/2017 14:09

"Varithena is the next big hope for a turning point" now where have I heard that before? I sold out originally when they talked about a 'soft launch'. Set the flags flying after SO many years of development and so much promise

I did buy back and trade some more recently but out as it stands.

[bargainbob] 20/9/2017 12:31

Well thats me mostly out of BTG now, still have 30 % of my holding left .

Not liking the lack of positive news . Still think the market has not fully appreciated todays announcement . Good Luck All , Suspect i will re invest sometime unless the inflection point happens and I miss the boat .